Insulet Corp. Common 144A

(ILTCL)

By |

Profile

Insulet Corp was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000 to 145,000 insulin-dependent diabetics are using it worldwide.

Contact Information

Website: www.insulet.com
Email: ir@insulet.com
Main Phone: +1 978 600-7000
Address: 600 Technology Park Drive
Address 2: Suite 200
State: MA
City / Town: Billerica
Country: USA
Postal Code: 01821

Issuer Information

Exchange: OTO
CEO: Patrick J. Sullivan
Employees: 857
NAICS: Surgical and Medical Instrument Manufacturing(339112)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange OTCPK